R. Egbring

2.1k total citations
66 papers, 1.6k citations indexed

About

R. Egbring is a scholar working on Pulmonary and Respiratory Medicine, Hematology and Cancer Research. According to data from OpenAlex, R. Egbring has authored 66 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pulmonary and Respiratory Medicine, 32 papers in Hematology and 16 papers in Cancer Research. Recurrent topics in R. Egbring's work include Blood properties and coagulation (31 papers), Blood Coagulation and Thrombosis Mechanisms (23 papers) and Protease and Inhibitor Mechanisms (16 papers). R. Egbring is often cited by papers focused on Blood properties and coagulation (31 papers), Blood Coagulation and Thrombosis Mechanisms (23 papers) and Protease and Inhibitor Mechanisms (16 papers). R. Egbring collaborates with scholars based in Germany, United States and Finland. R. Egbring's co-authors include K. Havemann, Rainer Seitz, W Schmidt, G. Fuchs, M. Wolf, M. Gramse, Jan Devay, Sabine Haertel, W. Kreuz and Esther Meili and has published in prestigious journals such as Journal of Clinical Investigation, Blood and The American Journal of Medicine.

In The Last Decade

R. Egbring

65 papers receiving 1.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
R. Egbring 738 654 241 202 175 66 1.6k
Verena Schroeder 825 1.1× 740 1.1× 108 0.4× 124 0.6× 110 0.6× 60 1.7k
Walter Nußbaumer 524 0.7× 144 0.2× 86 0.4× 291 1.4× 317 1.8× 51 1.7k
Takeshi Matsumoto 564 0.8× 299 0.5× 396 1.6× 302 1.5× 131 0.7× 98 1.6k
Rendrik F. Franco 1.2k 1.6× 191 0.3× 388 1.6× 225 1.1× 44 0.3× 63 2.1k
Toshihiro Kaneko 506 0.7× 158 0.2× 240 1.0× 120 0.6× 77 0.4× 33 926
H. Heinrichs 479 0.6× 216 0.3× 375 1.6× 313 1.5× 347 2.0× 29 2.0k
Kenneth D. Friedman 2.0k 2.7× 178 0.3× 287 1.2× 334 1.7× 134 0.8× 98 3.0k
Donald I. Feinstein 656 0.9× 219 0.3× 71 0.3× 194 1.0× 28 0.2× 49 1.4k
Zafer Gülbaş 1.2k 1.7× 139 0.2× 68 0.3× 134 0.7× 69 0.4× 142 2.1k
W. Andrew Heaton 742 1.0× 168 0.3× 98 0.4× 183 0.9× 148 0.8× 47 1.5k

Countries citing papers authored by R. Egbring

Since Specialization
Citations

This map shows the geographic impact of R. Egbring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Egbring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Egbring more than expected).

Fields of papers citing papers by R. Egbring

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Egbring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Egbring. The network helps show where R. Egbring may publish in the future.

Co-authorship network of co-authors of R. Egbring

This figure shows the co-authorship network connecting the top 25 collaborators of R. Egbring. A scholar is included among the top collaborators of R. Egbring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Egbring. R. Egbring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kreuz, W., et al.. (2005). Efficacy and tolerability of a pasteurised human fibrinogen concentrate in patients with congenital fibrinogen deficiency. Transfusion and Apheresis Science. 32(3). 247–253. 100 indexed citations
2.
Kreuz, W., et al.. (2005). Pharmacokinetic properties of a pasteurised fibrinogen concentrate. Transfusion and Apheresis Science. 32(3). 239–246. 61 indexed citations
3.
Szűcs, Sándor, Helga Bárdos, M Kávai, et al.. (2004). Possible role of factor XIII subunit A in Fcγ and complement receptor-mediated phagocytosis. Cellular Immunology. 228(2). 81–90. 53 indexed citations
4.
Wirth, Thomas, et al.. (2001). Prevention of venous thromboembolism after knee arthroscopy with low–molecular weight heparin (Reviparin). Arthroscopy The Journal of Arthroscopic and Related Surgery. 17(4). 393–399. 101 indexed citations
5.
Wolf, M., et al.. (1997). Prognostic impact of an activation of coagulation in lung cancer. Annals of Oncology. 8(8). 781–784. 19 indexed citations
6.
Yee, Vivien C., László Muszbek, Martti Syrjälä, et al.. (1996). Molecular basis of factor xiii deficiency H.Mikkola. Fibrinolysis & proteolysis. 10. 78–78. 1 indexed citations
7.
Heiden, M., Rainer Seitz, & R. Egbring. (1996). The Role of Inflammatory Cells and Their Proteases in Extravascular Fibrinolysis. Seminars in Thrombosis and Hemostasis. 22(6). 497–501. 28 indexed citations
8.
Seitz, Rainer, et al.. (1995). Thrombomodulin and ristocetincofactor in homocystinuria: A study in two siblings. Thrombosis Research. 77(1). 79–86. 5 indexed citations
9.
Maasberg, M., et al.. (1993). Activators of coagulation in cultured human lung‐tumor cells. International Journal of Cancer. 53(3). 514–520. 15 indexed citations
10.
Hergesell, Olaf, R. Egbring, & K. Andrássy. (1993). Presence of Anticardiolipin Antibodies Discriminates Between Wegener’s Granulomatosis and Microscopic Polyarteritis. Advances in experimental medicine and biology. 336. 393–396. 8 indexed citations
11.
Seitz, Rainer, et al.. (1993). Protein S degradationin vitroby neutrophil elastase. Scandinavian Journal of Clinical and Laboratory Investigation. 53(3). 281–288. 21 indexed citations
12.
Hemmer, Christoph Josef, Peter Kern, R. Egbring, et al.. (1991). Activation of the host response in human plasmodium falciparum malaria: Relation of parasitemia to tumor necrosis factor/cachectin, thrombin-antithrombin III, and protein C levels. The American Journal of Medicine. 91(1). 37–44. 61 indexed citations
13.
Seitz, Rainer, M. Wolf, R. Egbring, & K. Havemann. (1989). The disturbance of hemostasis in septic shock: role of neutrophil elastase and thrombin, effects of antithrombin III and plasma substitution*. European Journal Of Haematology. 43(1). 22–28. 75 indexed citations
14.
Seitz, Rainer, M. Wolf, R. Egbring, & K. Havemann. (1988). Neutrophil Elastase, Thrombin and Plasmin in Septic Shock. Advances in experimental medicine and biology. 240. 481–484. 1 indexed citations
15.
Seitz, Rainer, et al.. (1985). Fibronectin plasma levels after cadaver kidney transplantation. Annals of Hematology. 50(1). 35–43.
16.
Fuchs, G., R. Egbring, & K. Havemann. (1977). Fibrinogen marburg a new genetic variant of fibrinogen. Annals of Hematology. 34(2). 107–118. 24 indexed citations
17.
Egbring, R., et al.. (1976). Erfahrungen bei der Langzeitbehandlung des angeborenen Faktor XIII-Mangels mit Faktor XIII-Konzentrat. Annals of Hematology. 33(6). 367–375. 3 indexed citations
18.
Schmidt, W, R. Egbring, & K. Havemann. (1975). Effect of elastase-like and chymotrypsin-like neutral proteases from human granulocytes on isolated clotting factors. Thrombosis Research. 6(4). 315–326. 95 indexed citations
19.
Egbring, R., W Schmidt, & K. Havemann. (1973). Die vereinfachte radiologische Faktor-XIII-Bestimmung und ihre klinische Anwendung bei kongenitalem Faktor-XIII-Mangel (I). Annals of Hematology. 27(1). 6–19. 18 indexed citations
20.
Egbring, R., et al.. (1971). Diagnostische und therapeutische Probleme bei congenitaler Afibrinogenämie. Annals of Hematology. 22(4). 175–201. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Verena Schroeder Breakdown of academic impact, for papers by Walter Nußbaumer Breakdown of academic impact, for papers by Takeshi Matsumoto Breakdown of academic impact, for papers by Rendrik F. Franco Breakdown of academic impact, for papers by Toshihiro Kaneko Breakdown of academic impact, for papers by H. Heinrichs Breakdown of academic impact, for papers by Kenneth D. Friedman Breakdown of academic impact, for papers by Donald I. Feinstein Breakdown of academic impact, for papers by Zafer Gülbaş Breakdown of academic impact, for papers by W. Andrew Heaton
Rankless by CCL
2026